These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 29377347

  • 1. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
    Hou H, Ge C, Sun H, Li H, Li J, Tian H.
    Cancer Sci; 2018 Apr; 109(4):1088-1100. PubMed ID: 29377347
    [Abstract] [Full Text] [Related]

  • 2. Scorpion inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Yan YQ, Xie J, Wang JF, Shi ZF, Zhang X, Du YP, Zhao XC.
    Exp Biol Med (Maywood); 2018 Apr; 243(7):645-654. PubMed ID: 29486578
    [Abstract] [Full Text] [Related]

  • 3. The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug-resistance in hepatocellular carcinoma.
    Zhang X, He B, Chen E, Lu J, Wang J, Cao H, Li L.
    J Cell Physiol; 2021 Jan; 236(1):178-192. PubMed ID: 32510618
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
    Gao C, Li X, Yu S, Liang L.
    J BUON; 2019 Jan; 24(5):1964-1969. PubMed ID: 31786862
    [Abstract] [Full Text] [Related]

  • 5. Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK-VEGF/MMPs signaling pathway.
    Tian L, Huang Y, Liu Y, Liu J, Liu Y.
    IUBMB Life; 2024 Nov; 76(11):972-986. PubMed ID: 38873890
    [Abstract] [Full Text] [Related]

  • 6. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY.
    Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
    [Abstract] [Full Text] [Related]

  • 7. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
    Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han Y, Yin L, Cai C, Guo C, Shen H.
    Sci Rep; 2017 Jan 30; 7():41616. PubMed ID: 28134289
    [Abstract] [Full Text] [Related]

  • 8. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
    Li T, Zhong J, Dong X, Xiu P, Wang F, Wei H, Wang X, Xu Z, Liu F, Sun X, Li J.
    Oncol Rep; 2016 Jun 30; 35(6):3614-22. PubMed ID: 27109804
    [Abstract] [Full Text] [Related]

  • 9. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo.
    Yao S, Ye J, Yin M, Yu R.
    Cancer Lett; 2020 Jul 28; 483():87-97. PubMed ID: 32268165
    [Abstract] [Full Text] [Related]

  • 10. Anti‑cancer effects of a novel Pan‑RAF inhibitor in a hepatocellular carcinoma cell line.
    Wang W, Xu B, Li Q, Jiang D, Yan S.
    Mol Med Rep; 2018 Apr 28; 17(4):6185-6193. PubMed ID: 29484394
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.
    Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of ERK1/2 Signaling Impairs the Promoting Effects of TGF-β1 on Hepatocellular Carcinoma Cell Invasion and Epithelial-Mesenchymal Transition.
    Liu L, Li N, Zhang Q, Zhou J, Lin L, He X.
    Oncol Res; 2017 Nov 02; 25(9):1607-1616. PubMed ID: 28492136
    [Abstract] [Full Text] [Related]

  • 13. Columbamine suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK1/2 MAPK signaling pathways.
    Lin Z, Li S, Guo P, Wang L, Zheng L, Yan Z, Chen X, Cheng Z, Yan H, Zheng C, Zhao C.
    Life Sci; 2019 Feb 01; 218():197-204. PubMed ID: 30582951
    [Abstract] [Full Text] [Related]

  • 14. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma.
    Su Q, Fan M, Wang J, Ullah A, Ghauri MA, Dai B, Zhan Y, Zhang D, Zhang Y.
    Cell Death Dis; 2019 Dec 09; 10(12):939. PubMed ID: 31819036
    [Abstract] [Full Text] [Related]

  • 15. Calunduloside E inhibits HepG2 cell proliferation and migration via p38/JNK-HMGB1 signalling axis.
    Wang S, Chen X, Cheng J, Cai T, Wu X, Cheng Z, Qi S, Qi Z.
    J Pharmacol Sci; 2021 Sep 09; 147(1):18-26. PubMed ID: 34294368
    [Abstract] [Full Text] [Related]

  • 16. Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.
    Yang C, Qin S.
    Cancer Med; 2018 Sep 09; 7(9):4570-4583. PubMed ID: 30109780
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
    Zhou Q, Huang T, Jiang Z, Ge C, Chen X, Zhang L, Zhao F, Zhu M, Chen T, Cui Y, Li H, Yao M, Li J, Tian H.
    Oncogene; 2020 Mar 09; 39(10):2140-2155. PubMed ID: 31819169
    [Abstract] [Full Text] [Related]

  • 18. Multi-omics analysis reveals mechanism of Schisandra chinensis lignans and acteoside on EMT in hepatoma cells via ERK1/2 pathway.
    Jiang J, Cheng R, Song A, Lou Y, Fan G.
    Funct Integr Genomics; 2024 Jun 08; 24(3):112. PubMed ID: 38849609
    [Abstract] [Full Text] [Related]

  • 19. Osthole inhibits the tumorigenesis of hepatocellular carcinoma cells.
    Lin ZK, Liu J, Jiang GQ, Tan G, Gong P, Luo HF, Li HM, Du J, Ning Z, Xin Y, Wang ZY.
    Oncol Rep; 2017 Mar 08; 37(3):1611-1618. PubMed ID: 28184928
    [Abstract] [Full Text] [Related]

  • 20. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway.
    Chen K, Zhang S, Ji Y, Li J, An P, Ren H, Liang R, Yang J, Li Z.
    PLoS One; 2013 Mar 08; 8(9):e72927. PubMed ID: 24039823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.